Gyre Therapeutics (GYRE) Capital Expenditures Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 227.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.57% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 143.40% |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | 45.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.90% |
| Dec 31, 2025 | 321.54% |
| Sep 30, 2025 | -3.61% |
| Jun 30, 2025 | -82.42% |
| Mar 31, 2025 | -47.19% |
| Dec 31, 2024 | -102.80% |
| Sep 30, 2024 | -64.89% |
| Jun 30, 2024 | -41.22% |
| Mar 31, 2024 | -86.74% |
| Sep 30, 2021 | 152.31% |
| Sep 30, 2020 | 19,400.00% |
| Jun 30, 2020 | -67.35% |
| Mar 31, 2020 | 13.33% |
| Dec 31, 2019 | -100.57% |
| Jun 30, 2019 | 1,533.33% |
| Mar 31, 2019 | -92.42% |
| Dec 31, 2018 | 775.00% |
| Mar 31, 2018 | 6,500.00% |
| Dec 31, 2017 | -83.61% |
| Mar 31, 2017 | -96.63% |
| Dec 31, 2016 | 24.49% |
| Dec 31, 2013 | -126.15% |
| Jun 30, 2013 | -75.82% |
| Mar 31, 2013 | 52.17% |
| Dec 31, 2012 | -22.62% |
| Sep 30, 2012 | -99.40% |
| Jun 30, 2012 | -78.02% |
| Mar 31, 2012 | -92.31% |
| Dec 31, 2011 | -84.36% |
| Sep 30, 2011 | -15.23% |